Samil Pharmaceutical Co Ltd
000520
Company Profile
Business description
Samil Pharmaceutical Co Ltd is engaged in the manufacture and sale of pharmaceuticals and quasi-drugs and related businesses, and its main products and goods include Polybutin, Gliptide, Brufen, Ribact, and Hiabaks.
Contact
155 Hyoryeong-ro
Bangbae-dong, Samil Pharmaceutical Building
Seocho-Gu
Seoul
KORT: +82 25200300
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
598
Stocks News & Analysis
stocks
More gas left in the tank for ASX highflyer
Shares jumped after results and are screening as overvalued.
stocks
Ahead of Earnings, is Apple stock a buy, a sell, or fairly valued?
Following strong holiday sales and a recent AI deal, here’s what we’re watching for in Apple’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,143.05 | 5.84 | -0.07% |
| DAX 40 | 24,900.71 | 44.24 | 0.18% |
| Dow JONES (US) | 49,098.71 | 285.30 | -0.58% |
| FTSE 100 | 10,143.44 | 6.61 | -0.07% |
| HKSE | 26,710.76 | 80.80 | 0.30% |
| NASDAQ | 23,501.24 | 65.22 | 0.28% |
| Nikkei 225 | 52,690.39 | 998.50 | -1.86% |
| NZX 50 Index | 13,460.74 | 96.13 | -0.71% |
| S&P 500 | 6,915.61 | 2.26 | 0.03% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,140.73 | 4.57 | 0.11% |